Medical journals are supposed to be at the forefront of scientific discovery, but they're often stuck in their ways. They follow the same old rules, and it's not always good for progress. Over the last 50 years, the pharmaceutical industry has been pulling the strings more and more. This means that the stories these journals tell are often biased. These dominant sto...
The U. S. Food and Drug Administration (FDA) has announced that the long-standing shortage of semaglutide, the active ingredient in Novo Nordisk's weight loss injection Wegovy and diabetes treatment Ozempic, has finally been resolved. This decision comes after more than two years of scarcity, which has significantly impacted patients and the pharmaceutical industry. ...
Trump is planning to slap a 25% tariff on auto imports, semiconductors, and pharmaceuticals as early as April 2. This move comes after he already imposed a 10% tariff on Chinese goods and a 25% tariff on steel and aluminum imports. He hinted that these new tariffs could go even higher over the next year, but he wants to give companies a chance to move their factories...
China's drug scene has seen a huge change in the past 30 years. It used to be all about copying existing medicines, but now it's moving towards creating new ones. This shift is a big deal, but it's not all smooth sailing. One major hurdle is the lack of enough money for local research. Another issue is the weak bond between universities and drug companies. Plus, gett...
In recent years, the biopharmaceutical industry has seen a significant shift. Chinese companies are now at the forefront of developing innovative drugs. This trend has caught the attention of U. S. pharmaceutical giants, who are increasingly looking to China for promising new treatments. One notable example is the experimental cancer drug developed by a Chinese comp...
Let's talk about how the pharmacy has changed over the years. The global pharmacy industry has transformed rapidly. Lots of money moving around has changed the companies making medicines. It's now known as the Health Industrial Complex. Medicines used to be cheaper, but now they're designed to make lots of money. The World Trade Organization(WTO) managed a game...
Pfizer recently shared its fourth-quarter 2024 earnings. Their reported sales for COVID-19 products skyrocketed beyond what experts had guessed. This achievement was made possible by the company’s ongoing efforts to reduce costs. Shares of Pfizer went up by 2% in early trading. This jump came after they reported earnings, with results that were much better t...
We all rely on medicine to live healthy lives. Let's get into the big game where major countries compete to control access to medicine. Think of it as a race, but one where there's no finish line. China, India, and the United States are the top contenders. The United States owns the research and on the money front. If you ever wondered how a medicine works, chances ...
Imagine a world where government subsidies significantly impact the decisions of pharmaceutical companies. This isn't just a hypothetical scenario; it's a reality shaped by the strategic interplay between public investment and corporate innovation. Let's dive into the complexities of this dynamic. Pharmaceutical firms are constantly making big choices about ...
Ever wondered why pharmaceutical CEOs might need extra education? Well, it's not just about business and finance anymore. These top bosses often struggle with understanding the complex world of research and development (R&D). Unlike their staff, who spend years learning the ropes, CEOs may not grasp the ins and outs of discovering new medicines, ensuring safety, or m...